[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported multiple transactions in common stock and stock options in a Form 4 filing. The filing shows sales of 1,000 shares on 09/11/2025 at $38.66 and on 09/12/2025 and 09/15/2025 at $40.00, and purchases of 1,000 shares on 09/12/2025 and 09/15/2025 at $16.91 under reported transactions. Following these transactions, reported beneficial ownership of common stock moved between 38,754 and 39,754 shares as shown. The filing also discloses several non-qualified stock options with exercise prices ranging from $16.91 to $33.36 and various vesting schedules, with specific vesting and expiration dates noted.

Positive

• Sales were effected pursuant to a Rule 10b5-1 trading plan, indicating pre-planned transactions
• Detailed vesting schedules for multiple option grants are disclosed, showing structured equity incentives
• Filing discloses specific prices, dates and post-transaction holdings, supporting transparency

Negative

• Insider reported multiple share sales (1,000 shares on 09/11/2025 and additional sales on 09/12/2025 and 09/15/2025), which reduce direct holdings
• No explanation of purpose for purchases at $16.91 versus sales near $40.00 beyond the 10b5-1 statement in the filing

Insights

Financial Analyst

TL;DR: Routine insider sales under a Rule 10b5-1 plan plus option holdings; transactions primarily reflect planned trading and option vesting schedules.

The Form 4 indicates that the CFO executed multiple sell and buy transactions in common stock on 09/11/2025, 09/12/2025 and 09/15/2025, including sales reported as effected pursuant to a Rule 10b5-1 trading plan. Reported purchases at $16.91 and sales near $40.00 changed beneficial ownership between 38,754 and 39,754 shares. The filing also itemizes non-qualified stock options with exercise prices of $16.91, $24.35, $26.18, $27.59 and $33.36 and various vesting schedules and expirations through 03/04/2035. For investors, these are disclosure of insider liquidity and ongoing equity incentives rather than an operational update.

Corporate Governance Expert

TL;DR: Disclosures follow standard governance practices; sales were executed under a Rule 10b5-1 plan and multiple option grants include staggered vesting.

The Form 4 provides clear disclosure of planned share sales under a Rule 10b5-1 trading plan and detailed option vesting terms, including multi-year vesting schedules and exercisable amounts. The filing is transparent about the nature of indirect ownership and vesting timelines, which supports standard insider trading compliance and equity compensation governance. No amendments or corrective notes are present in the filing text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BAKER COREY

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		S(1)		1,000	D	$38.66	38,754	D
Common Stock	09/12/2025		M		1,000	A	$16.91	39,754	D
Common Stock	09/12/2025		S(1)		1,000	D	$40	38,754	D
Common Stock	09/15/2025		M		1,000	A	$16.91	39,754	D
Common Stock	09/15/2025		S(1)		1,000	D	$40	38,754	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$16.91	09/12/2025		M			1,000	(2)	03/10/2033	Common Stock	1,000	$0.0	13,205	D
Non-Qualified Stock Option (right to buy)	$16.91	09/15/2025		M			1,000	(2)	03/10/2033	Common Stock	1,000	$0.0	12,205	D
Non-Qualified Stock Option (right to buy)	$24.35							(3)	05/10/2033	Common Stock	13,481		13,481	D
Non-Qualified Stock Option (right to buy)	$26.18							(4)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$27.59							(3)	08/07/2033	Common Stock	11,547		11,547	D
Non-Qualified Stock Option (right to buy)	$33.36							(5)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option vests in four equal annual installments beginning on March 10, 2024.

3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.

4. The stock option vests in four equal annual installments beginning on March 4, 2025.

5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Corey Baker	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did COCO CFO Corey Baker report on the Form 4?

Corey Baker reported sales of 1,000 shares on 09/11/2025 at $38.66, sales of 1,000 shares on 09/12/2025 and 09/15/2025 at $40.00, and purchases of 1,000 shares on 09/12/2025 and 09/15/2025 at $16.91.

Were any sales executed under a trading plan in the COCO Form 4?

Yes. The filing states the sales of common stock were effected pursuant to a Rule 10b5-1 trading plan.

What stock options does the Form 4 disclose for Corey Baker?

Non-qualified stock options with exercise prices of $16.91, $24.35, $26.18, $27.59 and $33.36 are disclosed, with various vesting schedules and expirations through 03/04/2035.

How many shares did Corey Baker beneficially own after the reported transactions?

Reported beneficial ownership after transactions ranged between 38,754 and 39,754 shares depending on the specific transaction reported.

Do the option grants include staged vesting?

Yes. The filing specifies multi-year vesting schedules, including four-equal-installment vesting and other staggered vesting dates.